Latest news
Sanofi asked to change Dupixent ads after Galderma challenge - Fierce PharmaFierce Pharma · Thu, 06 Aug 2026 11:40:54 GMTRegeneron: Dupixent Sales Reach $6 Billion As Sanofi Repayment Unlocks Profit And Cash Flow Inflection - Pulse 2.0Pulse 2.0 · Sun, 02 Aug 2026 21:22:29 GMTSanofi (Nasdaq: SNY) Raises 2026 Sales Guidance - Value The MarketsValue The Markets · Fri, 31 Jul 2026 07:00:00 GMTSanofi drug pipeline worries, Dupixent dependence shake shares - ReutersReuters · Thu, 30 Jul 2026 19:41:50 GMTSanofi raises outlook as quarterly Dupixent sales cross €5B for first time - FirstWord PHARMAFirstWord PHARMA · Thu, 30 Jul 2026 15:21:36 GMTSanofi lifts sales growth forecast on Dupixent strength in boost for new CEO - 927thevan.com927thevan.com · Thu, 30 Jul 2026 09:33:52 GMTNew CEO Garijo sketches out vision to reverse Sanofi's fortunes as Q2 delivers impressive sales beat - Fierce PharmaFierce Pharma · Thu, 30 Jul 2026 07:00:00 GMT